Jianzhijia Pharmaceutical Chain Group Co., Ltd.

SHSE:605266 Lagerbericht

Marktkapitalisierung: CN¥3.7b

Jianzhijia Pharmaceutical Chain Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Jianzhijia Pharmaceutical Chain Group has been growing earnings at an average annual rate of 13%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 22.2% per year. Jianzhijia Pharmaceutical Chain Group's return on equity is 8.5%, and it has net margins of 2.5%.

Wichtige Informationen

13.0%

Wachstumsrate der Gewinne

5.7%

EPS-Wachstumsrate

Consumer Retailing Wachstum der Industrie12.8%
Wachstumsrate der Einnahmen22.2%
Eigenkapitalrendite8.5%
Netto-Marge2.5%
Letzte Ertragsaktualisierung30 Sep 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt

Oct 03
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt

What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?

Jul 16
What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?

Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%

Jun 19
Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%

Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet

Feb 27
Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet

Aufschlüsselung der Einnahmen und Ausgaben

Wie Jianzhijia Pharmaceutical Chain Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

SHSE:605266 Einnahmen, Ausgaben und Erträge (CNY Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Sep 249,3162372,8960
30 Jun 249,2283192,8010
31 Mar 249,2283902,7060
31 Dec 239,0814142,5860
30 Sep 239,3054572,5790
30 Jun 238,8464422,4280
31 Mar 238,2314192,2750
31 Dec 227,5143742,1250
30 Sep 226,2773001,8440
30 Jun 225,8622681,7140
31 Mar 225,5182671,5880
31 Dec 215,2353011,4780
30 Sep 214,9472761,3820
30 Jun 214,7372621,3090
31 Mar 214,5782621,2300
31 Dec 204,4662511,1880
30 Sep 204,2132151,0980
31 Dec 193,5291689950
31 Dec 182,7661348320
31 Dec 172,347957120
31 Dec 162,054716700
31 Dec 151,844186340
31 Dec 141,667175620

Qualität der Erträge: 605266 has high quality earnings.

Wachsende Gewinnspanne: 605266's current net profit margins (2.5%) are lower than last year (4.9%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 605266's earnings have grown by 13% per year over the past 5 years.

Beschleunigtes Wachstum: 605266's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Erträge im Vergleich zur Industrie: 605266 had negative earnings growth (-48.1%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).


Eigenkapitalrendite

Hohe Eigenkapitalrendite: 605266's Return on Equity (8.5%) is considered low.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren